OMass Technologies
Charles Lay has worked for a range of companies since 2012. Theirfirst role was a Work Experience role at Maidstone and Tunbridge Wells NHS Trust in 2013. In 2012, they had a Work Experience role at Marsh. In 2016, they were an Industrial Placement Student at GlaxoSmithKline Pharma GmbH. From 2018 to 2022, they were a PhD Student at the University of Nottingham. Most recently, they have been a Scientist at OMass Therapeutics since 2022.
Charles Lay attended The Skinners' School from 2007 to 2014. Charles then went on to pursue a degree in Biochemistry with Industrial Experience at the University of Exeter from 2014 to 2018. Currently, they are enrolled in a Doctor of Philosophy - PhD program in Molecular Pharmacology and Drug Discovery at the University of Nottingham, which they are expected to complete in 2022.
This person is not in any offices
OMass Technologies
1 followers
OMass Technologies is a drug discovery company exploiting novel mass spectrometry platforms to develop therapeutics.